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Dermal lymphocytic infiltrates are characteristic of psoriasis 
and may be involved in the pathogenesis of the disease. W e 
have utilized an in vitro lymphocyte adherence assay to ex-
amine the mechanism{s} mediating lymphocyte migration 
into psoriatic skin. In this assay, we assessed the binding of 
lymphocytes overlaid onto frozen biopsy sections of normal 
and psoriatic skin. Lymphocytes isolated from human blood 
and rat thoracic duct bound specifically to dermal endothelia 
in psoriatic plaques but not to those of uninvolved skin from 
psoriatic patients or skin from normal individuals; analysis of 
the binding properties of B cells and T lymphocyte subsets 
revea led a preferential binding of CD4+ T cells compared 
with CD8+ T cells or B cells. This lymphocyte-endothelial 
interaction is an energy- and calcium-dependent process and 
Psoriasis is characterized by excess ive epidermal prolifera-tion and by dermal infiltrates that are largely composed of T cell s and macrophages [1,2]. The development of psoriatic lesions ·is associated with dermal influx of CD4+ T cell s in close proximity with HLA-DR+ den-
dritic cells [3]. In contrast, the resolution of lesions often coincides 
w ith an increased epidermal entry of CD8+ T ce lls [4]. Thus, inter-
actions between infiltrating CD4+ T cel ls and antigen-presenting 
cells in the epidermis may be important in the initiation and mainte-
nance of psoriatic lesions [5]. and the recent successful treatment of 
psoriasis with cyclosporin A [6] lends support for an immunologic 
component in the pathogenesis of the disease. 
The mechanisms underlying the preferential recruitment of 
C D4+ T ce ll s into psoriatic lesions are not known. In order for 
lymphocytes to enter the epidermis from the dermis, they must first 
emigrate from the vasculature. We have previously shown that 
Iymphocytotropism in cutaneous lesions may be mediated by adher-
ence of lymphocytes to specialized dermal endothelium. Studies 
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invo lves surface protein and carbohydrate moieties, require-
ments similar to those found in lymphocyte interaction with 
post-capill ary hi gh endothelial venules (HEV) in lymphoid 
ti ssues. However, preincubation of lymphocytes with anti-
bodies directed against surface molecules mediating adhesion 
to HEV of peripheral lymph node and gut-associated lymph-
oid tissue did not interfere with the capacity of lymphocytes 
to bind to the skin. The results of this study support the 
hypothes is that emigration of lymphocytes from vasculature 
into psoriatic skin is promoted by the presence of specialized 
endothelia in psoriatic dermis capable of mediating specific 
lymphocyte-endothelial interactions . ] In vest Dermatol 
91:423-428, 1988 
using an in vitro lymphocyte-frozen skin section adherence assay 
have shown that endothelial cells lining dermal vessels in cutaneous 
tumors bind lymphocytes; normal skin does not display lymphocyte 
adherence, whereas tumor vessels exhibit preferential adh erence of 
CD4+ T ce lls as compared to CD8+ T cells and E cells. In the 
present study, we examined the capacity of dermal vessels in psoria-
sis to mediate selective lymphocyte adherence. The results support a 
role for dermal endothelium in regul ating the traffic ofl ymphocyte 
subsets into psoriatic lesions. 
MATERIALS A~D METHODS 
P~ticnts Periphera l blood and skin sa mpl es were obtained from 10 
patients with psoriasis. The age of the patients ranged from 32 to 78 
yea rs and there were six women and four men. The extent of the 
psoriasis was of generalized (25% to 60% of body surface) plaque 
type in six patients, involvement limited to the extensor surfaces in 
two, guttate lesions in one, and erythrodermic psoriasis in one pa-
tietlt . N one of the subjects had received systemic or topical treat-
ment for at least 6 weeks, and all of the patients had undergone 
clinica l progression of their disease. Seven of tbe patients had pre-
viously received UVE treatment and two of them had been treated 
with PUV A. Two patients had previously received systemic metho-
trexate and one of these two patients had used hydroxyurea and 
topica l nitrogen mustard 10 years before this study. After informed 
consent was given, 6-mm punch biopsies were taken of psoriatic 
skin in ~ddition to clini ca ll y uninvolved areas ata distance of at least 
3 cm froll1 lesional skin . In all cases, the biopsy specimen was ob-
tained from a central area of the psoriatic plaque, away from th e 
periphery. We used 2% lidocaine without epinephrine to anesthe-
tize the skin . The specimens were immediately frozen and stored in 
liquid nitrogen. For sectioning of tissues, samples were embedded in 
O.C.T. compound (T issue Tek II , Miles Scientific). 
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Cell Preparation Human peripheral blood mononuclear cells 
(PBMe) from psoriatic patients or volunteers were prepared by 
centrifugation of defibrinized venous blood over Ficoll-Hypaque 
gradients (Pharmacia Fine C hemicals, Piscataway, N.J.) [7J. The 
cells in the interface were collected, washed 2X in RPMI-1640 
medium (Gibco, Grand Island, NY) containing 1 % heat-inactivated 
fetal calf serum (FCS), and resuspended at the indicated concentra-
tions. 
Thoracic ducts of Sprague-Dawley rats were cannulated and 
lymph was collected at room temperature in 20 ml PBS with 5 unit 
heparin/ml as described [8J. Thoracic duct lymphocytes (TDL) 
used in this study were obtained from lymph coll ected for 3-4 h 
beginning at 20 h after cannulation. The cells were washed 3X in 
RPMI-1640 containing 1% FCS before use. 
Separation ofTD L into T-cell enriched and B-cell enriched pop-
ulations was achieved using the nylon woo l filtration method as 
described [9J . The non-adherent fraction was the source ofT cells 
(90% to 95% positive for OX 19+, a pan T-cell marker) and the 
adherent fraction was the source ofB cells (90% - 95% surface Ig+). 
Lymphocyte-Adherence Assay The procedure for the in vitro 
binding of human or rat lymphocytes to frozen sections ofbiopsied 
skin was adapted from the rat lymphocyte-lymph node binding 
assay and has been described in detail elsewhere [10] . Briefly, 8-,um-
thick frozen sections obtained from a single biopsy were mounted 
individually on precleaned microslides and fixed with 3% glutaral-
dehyde (Polyscience, Warrington, PA) in O.IM sodium cacodylate 
buffer. After fixation, slides were rinsed in buffer and unreactive 
carboxyl groups were blocked by treatment with 0 .2 M lysine mon-
ohydrochloride. Slides contain ing sections in sequential order were 
placed on 5 X 10 cm plastic trays (four slides/tray), a 0.2 ml aliquot 
of the indicated cell suspension was deposited over each section, and 
the trays were placed on a rotating table operating at 80 rpm. Incu-
bation was at r C for 30 min. The non-adherent cells were rinsed 
off with phosphate buffered saline, and the sections were refixed 
w ith glutaralde hyde and stained with methyl-green thionine. The 
results are expressed as the number of lymphocytes bound per mm2 
of sections. The values reported are means of several sections ± S.E.; 
the probability (p) values were determined by Student's t-test. 
Quantitation of the Adherence of Lymphocytes to Tissue 
Sections The tissue sections were examined by li ght microscopy 
and the number of adherent cells per unit area was determined. This 
was accomplished with a calibrated ocular grid with squares having 
an area of approximately 120 11m2 at 40X magnification . Binding to 
the upper dermis was determined by scoring six separate fields, each 
containing 8 squares. The density of lymphocytes bound per mm2 
was then calculated as described [9]. 
Enzyme Treatment of Lymphocytes Lymphocytes (2 X 107 
cel ls) were resuspended in 0.5 ml RPMI medium and incubated 
with 20 I1g of trypsin, neuraminidase, or glycosidase (Sigma C hem-
icals, St. Louis, MO) for 10 min at 37 °C. The cells were washed, 
resuspended in RPMI containing 5% FCS, and overlaid onto frozen 
tissue sections. The viabi lity of the treated lymphocytes was> 95% 
as determined by trypan blue exclusion. 
Antibody Treatment of Lymphocytes Rat thoracic duct lym-
phocytes (50 X 107 cells) were resuspended in 0.5 tnl RPMI me-
dium containing 25,ug of A.I1 IgG, 1B.2 IgG, or OX-1 antibody 
(Accurate Chemical Co., Long Island, NY) and incubated for 
30 min at 37 °C. T he A.11 and IB.2 monoclonal antibod ies are 
IgG2a and react with lymphocyte receptors specific for lymph node 
and Peyer's patch high endothelium, respectively [11 ,12J, and the 
OX-t, an IgG monoclonal antibody, reacts with leukocyte com-
mon antigen [13]. The cell s were then washed and resuspended in 
RPMI; each population of lymphocytes was viable (> 95%) and 
microscopically unagglutinated. Cell treatment was performed by 
using saturating amounts of monoclonal antibodies that were deter-
mined in indirect binding assays as described previously [11]. 
For anaJysis of the binding properties of antibody-treated lym-
phocytes to lymph nodes, tonsils, or psoriatic skin, the lymphocytes 
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were overlaid onto duplicate trays containing four sequential sec, 
tions of each tissue with two sections overlaid with A.ll-or IB.2, 
treated TDL and two sections overlaid with OX-l treated lympho" 
cytes. The lymphocyte adherence assay was carried out ill the 
standard manner. The values reported are the means of at least fou~ 
sections ± SE; probability (P) values were determined by using 
Student's t-test. 
Preparation ofT-Cell Subsets Rat T-cell subsets were prepared 
by panning of the T-cell enriched fraction using the W3/25 Ot 
OX-8 monoclonal antibodies (botb from Accurate Chemical Co., 
Long Island, NY) as described previously (14]. The W3/25 anti_ 
body reacts mainly with helper/in.ducer T cells, while the OX-8 
antibody identifies the suppressor/cytotoxic T-cell subset [13]. 
Briefly, the nylon-wool non-adherent cells (5 X 107 cells) were 
incubated with 20/-lg of IgG fraction of W3/25 or OX-8 for 45 
min, washed, and panned on goat anti-mouse Ig-coated petri dishes. 
The non-adherent cells were removed by gentle washing and the 
adherent cell s were eluted by vigorous pipeting with PBS. The 
panning procedure was repeated once and the purity of the respec_ 
tive adherent populations was> 90% W3/25+ or OX-8+, as deter_ 
mined by indirect inununofluorescence. 
Immunoperoxidase Techniques Frozen tissue sections (5 ,um) 
were fixed in acetone and blocked with 0.6% hydrogen peroxide for 
30 min . Immunoperoxidase staining was performed using rabbit 
anti- human collagen type IV antigen and the avidin/biotin/peroxi-
dase method (Vector Laboratories, Burlingame, CAl according to 
the manufacturer's instructions. A 3-min wash with 0.01 % Tween-
20 in PBS was added between each incubation to eliminate nonspe-
cific staining. Diaminobenzidine/hydrogen peroxide was used as 
the chromagen and sections were counterstained with hematoxylin. 
RESULTS 
Human peripheral blood mononuclear cells (PBMe) from psoriatic 
patients or from normal volunteers were overlaid onto frozen sec-
tions of psoriatic plaques and adhered selectively to the upper 
dermis. Binding occurred rapidly at 7°C with maximal levels of 
adherence found in 15 to 30 min. Overlaid lymphocytes were rarely 
found in the epidermis and they did not adhere to structures in the 
lower dennis . Those lymphocytes that did attach to the epidermis 
were randomly situated, widely spaced, and did not display any 
apparent regularity in their pattern of adherence. The concentration 
of lymphocytes ad hered per unit area of epidermis was 60- to 100-
fold lower than that of the papillary dermis. The patterns of adher-
ence in one of eight representative experiments is shown in Fig 
1A,B. The distribution of lymphocyte adherence was confined to 
the upper dermis. Analysis of lymphocyte adherence and of immu-
no peroxidase staining for human type IV collagen anti gen in se-
quential sections (Fig 1C,D) revealed that human PBMC ad hered 
specifically to areas staining positive for type IV collagen; this find-
ing is cons istent with an endothelial binding site. In parallel experi-
ments employing immunoperoxidase staining for hUl1un factor 
VIII-related antigen, identical pattems of staining and lymphocyte 
adherence were observed (not shown). Among the eight patients 
with plaque type psoriasis, lymphocyte adherence to the papillary 
dermis was hi gh ly reproducible with similar levels of lymphocyte 
binding to the frozen sections in each case (45 to 55 cel ls bound/ 
mm 2 of upper dermis) (Table I). In contrast, minimal ad herence was 
observed when human PBMC were overlaid onto frozen sections of 
non-involved skin from psoriasis patients, and there was absolutely 
no lymphocyte adherence to sections of normal skin (Table I) . 
Additional studies b:lVe shown that rat thoracic duct and lymph 
node cells were also able to adhere to the endothelium of the psoria-
tic dermal vessels . The pattern of binding of xenogeneic lympho-
cytes resembled that with human PBMC (data not shown), indicat-
ing that the properties oflymphocytes that mediate their affinity for 
the specia lized endothel ium are not species-restricted. Binding of 
the rat thoracic duct lymphocytes to the human psoriatic skin sec-
tions ex hibited identical cell dose dependency as compared to 
human peripheral blood lymphocytes (Fig 2). This observation thus 
A B 
c D 
Figure 1. A and B Methyl-green thionine stain of psoriatic plaque demonstrating dermal lymphocyte binding. Human lymphocytes were overlaid onto 
section as described in Materials a"d Methods. Lymphocyte binding is confined to discrete areas within the papillary dermis (arrows): there is minimal binding 
observed to epidermis and reticular dermis. (A: X 200; B: X 640) C and D: Sequential sections of psoriatic tissue showing lymphocyte adherence and presence 
of collagen type IV by ill1munoperoxidase technique. For lymphocyte adherence (C), rat thoracic duct lymphocytes were overlaid as described in Materials arid 
Methods. For immunopcroxidase (D) , 5-flm-thick sections were incubated with rabbit antihuman type IV collagen antibody, fo llowed by biotinylatcd goat 
anti-rabbit antiserum and avidin-conjugated developing reagents; sections were counter-stained with hcmatoxylin. Lymphocytcs adhered to areas staining 
positive for collagen (X 250). 
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Table I. Summary of Lymphocyte Adherence to Psoriatic 
Endothelium 
Number Lymphocyte 
Adherence/mm2' 
Involved Uninvolved Normal 
Patient Type of Psoriasis skin skin skin 
1 Plaque 47 ±3 3±1 0 
2 Plaque 45 ± 4 2±1 0 
3 Plaque 48 ± 3 0 0 
4 Plaque 52± 4 3±1 0 
5 Plaque 55 ± 5 4 ± 1 0 
6 Plaque 49± 6 3±1 0 
7 Plaque 46 ± 5 0 0 
8 Plaque 55 ± 6 3±1 0 
9 Guttae 38 ± 4 2± 1 0 
10 erythrodermic 45 ± 8 0 0 
• 2 X 10' human peripheral blood mononuclear cel ls were overlaid onto 8-lim-thick 
frozen sections. The ad herence assay and guantitation of binding were performed as 
described in Materials alld Methods. 
al lowed us to examine the mechanism of lymphocyte adherence by 
using rat lymphocytes and previously characterized monoclonal an-
tibody reagents directed against specific lymphocyte receptors for 
post-capillary high endothelium ofJymph nodes and gut-associated 
lymphoid tissue (Peyer's patch). Of note, immature cells, such as 
those prepared from the rat th ymus, are deficient in their capacity to 
ad here to the psoriatic skin sections, suggesting that the ability of 
lymphocytes to adhere is developmentally regulated (Fig 2) . 
Because CD4+ T cel ls predominate in psoriatic plaques [3], we 
next investigated the endothelial-binding properties of B cell s, T 
cell s, and their subsets. We used the nylon wool column technique 
to fractionate rat thoracic duct lymphocytes into predominantly 
surface Ig-pos itive (B) and OX-19 positive (T) populations: The 
results in Fig 3 indicate thatT and B cells were capable ofbmdmg to 
the endothelium in vitro but with different cell dose-response rela-
tionships, suggesting that these populations differ significantly in 
their binding capabilities. Further studies provided evidence that in 
vitro endothelial ad herence is mostly the property of CD4+ T cells: 
T cells were separated by panning usin g the W3/25 and OX-8 
monoclonal antibodies into CD4+ and CD8+ T cells, respectively, 
and quantitative assessment of the number of lymphocytes bi,nding 
to psoriatic sections revealed that the CD4+ T cells adhered slgl1lfi-
candy better than CD8+ T cells (Fig 4). This experiment was per-
formed with biopsies from four different patients and identical re-
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Figure 2. Adherence of rat lymphocytes and human peripheral blood 
mononuclear cells to psoriatic dermal endothehull1. Rat and human ceIls 
were prepared as described in Materials a'id Methods and overlaid onto psona-
tic ti ssue sections at different concentrations. Bar: standard error of the mean 
of at least four experiments; solid lille: rat thYll1us cells; dashed lille: rat TDL; 
dOl/ed {ill ei human PEL. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGy 
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Figure 3. Adherence ofB ce lls and T cells to psoriatic dermal endothelium. 
Rat thoracic duct lymphocyte populations were separated by nylon wool 
technique and overbid onto psoriatic tissue sections at varying concentra_ 
tions as indicated in the fi gure. Bar: standard error of the mean of fOli r 
cxpcrimcllts; solid /ille: T cells; dashed /ille: B cell s. 
slIlts we re obtained in each . T his observation is in accord with 
earlier histologic studies showing preferential recruitment of CD4+ 
T cel ls into the dermis in psorias is. 
Lymphocyte migration into lymph nodes is med.iated by adh~r­
ence to endothelial cells lining the post-capillary lugh endotheh al 
venules (HEV) [15]. In order to investigate whether lymphocyte 
adherence is mediated through an HEV -like interaction, the prop-
erties of human PBMe or rat TDL involved in adherence to the 
specialized endothelium were studied with enzymes th at modify 
lymphocyte surface structures and pharmacologic agents that alter 
metabolic processes. The results in 'Table II show that pretreatm~nt 
of lymphocytes with 10 mM sodium az id.e, an inhibitor of OXidative 
phosphorylation, caused dramatic redUCtlOllln bll1dll1g. The effects 
of sodium azide were largely reversible when the drug was removed 
and cel l viability was always> 90% (trypan blue exclusion). W e 
next studied the role of Ca++ and Mg++ in lymphocyte ad herence 
through the use of chelating agents. Binding of lymphocytes was 
inhibited by lmM EDTA or EGTA (Table II) . These effects were 
prevented by addition of CaCl2 (10 mM) to the medium but no 
reversal occurred by using M gCl2 (10 mM), In studies uSlI1g en-
zymes, treatment of human PBMC or ra.t TDL treated.w~th trypsin 
or glycosidase reduced their capacity to bllld to t~le speclaltzed endo-
thelium in vitro, but neuraminidase treatment did not reduce ad her-
W3/25 POSITIVE T LYMPHOCYTES 
ADHERE PREFERENTIALLY TO 
SPECIALIZED ENDOTHELIUM 
W3/20 
CELL POPULATIONS 
Figure 4. Adherence of T helper and suppressor cell s to psoriatic dermal 
endothelium. Rat thoracic duct lymphocyte T cells were separated by pan-
ning technique using specific helper (W3jZS) and suppressor (OX-B) mem-
branc markers. Figure shows binding of whole T cel ls, helper, and suppres-
sor subsets using suspension of 106 ce ll s for overlay . Data are mean and 
standard crror of four cxperimclJts. 
VOL. 91, NO.5 NOVEMBER 1988 
ence; this phenomenon has been observed in situations where lym-
phocyte migration occurred across the walls of HEV (reviewed in 
Ref 16). 
We have previously shown that lymphocyte adherence to HEV 
could be blocked by pretreatment with monoclonal antibodies 
against receptors to lymphocytes that mediate binding to HEV of 
lymph node and HEV of Peyer's patches, respectively [ 11,12]' W e 
therefore investigated whether the surface molecules responsible 
for lymphocyte adherence to lymph node and gut-associated 
lymphoid tissue playa role in lymphocyte adherence to psoriatic 
plaques. The resul ts in Table III show that pretreatment oflympho-
cytes with saturating amounts of A.11.S or 1B.2.6 antibodies 
blocked rat lymphocyte adherence to frozen sections of human 
ly mph node and tonsil, respectively, but did not interfere with the 
binding of these ce lls to the psoriatic skin sections, implying that a 
novel receptor/ ligand interaction mediates binding to the dermal 
endothelium. T his notion is further supported by a second line of 
evidence. Recent studies have shown that lymphocytes adhere to 
lymph node through recognition of carbohydrate moieties (mainly 
mannose-6-phosphate) on high endothelial cells [17]. The resu lts in 
Table IV show that preincubation oflymphocytes with mannose-6-
phosphate interfered with their ability to bind to lymph node but 
had no effect on binding to psoriatic endothelium. The effect of 
mannose-6-phosphate on lymph node binding was dose-dependent 
and highly specific; mannose-1-phosphate had no effect on binding 
of lymphocytes to either endothelium. 
DISCUSSION 
In this study th e migra tion of lymphocytes from the blood into the 
dermis of psoriatic plaques was investigated by using an in vitro 
lymphocyte-frozen psoriatic skin section adherence assay. In anal-
ogy to lymph nodes and tonsils, where lymphocytes emigrate from 
the blood by ad hering specifica lly to high endothelial venules, we 
have shown that specialized endothelium lining dermal vessels in 
involved psoriatic skin are capable of supporting lymphocyte bind-
ing and may represent sites where lymphocytes can leave the blood 
by passing through the endothelial wall. Furthermore, although 
both T and B cells were capable of binding, the data demonstrated 
preferential adherence by CD4+ T lymphocytes. Th is observation 
extends the prev iously reported immunohistologic studies showing 
selective CD4+ T-cell infiltration in the dermis of chronic psoriatic 
patients [3] and supports our notion that specialized endothelia me-
diate and promote lymphocyte entry into the diseased skin. 
We have found that the ability to recognize and bind to dermal 
endothel ium is a property of mature lymphocytes. Immature cells, 
such as those prepared from the thymus, are deficient in the binding 
capability. In addition, lymphocyte adherence requires energy, is 
calcium-dependent, and can be inhibited by brief treatment of lym-
phocytes with low concentrations of trypsin and glycosidase. T he 
cellular specificity and metabolic requirements of this interaction 
thus closely resemble those of lymphocyte binding to lymphoid 
HE V, supporting th e concept that lymphocyte migration into 
Table II. Factors Affectin g Bind in g of Lymphocytes to 
Specia lized Endothelium in Psoriatic Tissue Sections 
Treatment of Lymphocytes' 
Sodiul11 Azide 
EDTA 
EGTA 
EDTA + Ca++ 
EGTA + Mg++ 
Trypsin 
Glycosidase 
Neuraminidase 
% Inhibition of Bindingb 
90 
95 
90 
10 
85 
100 
90 
10 
a 10 X lO' lymphocyrcs incubated with the reagent for 10 min at 37 °C :\ nd overlaid 
ontO frozen tissue sections. Concentrations of reagents used were 10 mM sodium azide, 
1 111M EDTA and EGTA, 10 mM C"H and MgH and 20/lg of trypsin , glycos idase or 
neuraminidase. 
b Percent of inhibition is calculated by comparison of binding for treated and un· 
treated IYlllphocytes. 
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Table III. Lymphocyte Adhesion Molecul es for Lymph Node 
and Peyer's Patch High Endothelium do not Mediate 
Lymphocyte Binding to Psoriatic Endothelium 
# of Positive HEVh Number of Cells 
Bound per mm2 
Treatment of Cell' LN Tonsi ls Tissue 
A.I1.5 8 ± 3<·<1 27 ± 5 26 ± 5 
Controllg (OX-l) 52± 6 33 ± 5 38 ± 4 
1B.2.6 55 ± 6 2 ± 1.1 42± 4 
Controll g (OX-I) 60 ± 3 48 ± 5 37 ± 8 
'TDL treated with saturating amounts of monoclonal antibodies (2 X 10' cells/ 20 
/lg) for 37 ·C for 30 min. The ce lls were w.shed once and overlaid onto the tissue 
sections at 10 X 10"/m!. 
II Human LN and tonsil tisslie . Vcnulcs with two or morc lymphocytes adhered were 
scored positive. 
C Mean ± S.E. for 4 scctions. 
J p < 0.0 I by Student's t-tcst. 
dermis is med iated by specialized blood vessels pos~essing HEV -like 
properties. In addition, a recent study has also shown that high 
endothelial venu les, as measured by the presence of tannic acid 
staining material , were present in psoriatic skin [1B]. It is not known 
which mediators are responsible for the induction of the adherence 
capacity on the endothelium or by what cell type they may be 
produced. Studies are in progress to address these issues . 
Ce ll ad hesion generall y involves recognition of specific ligands 
by ce ll-surface receptors. It is well established that lymphocyte mi-
gration via HEV is regu lated by the presence of surface receptors or 
lymphocytes that recognize organ-specific determinants on the en-
dothelial membrane. Thus, the receptors for lymph node and 
Peyer's patches have been characterized by monoclonal antibodies 
and shown to be structurally related, but functionally distinct, mole-
cules with apparent M .W. ofBO-90 kilodaltons [11,1 2J. Recently, 
a third receptor on lymphocytes has been postulated to mediate 
lymphocyte ad herence to HEV-like vessels lining synovial mem-
branes in joints of patients with rheumatoid arthritis [1 9]. The data 
in Tables II and III suggest that the molecules responsible for lym-
phocyte adhesion to dermal endothelium are distinct from those 
mediat in g binding to high endothelium in peripheral lymph node 
and gut-associa ted lymphoid tissue (tonsil). We do not know 
whether these molecules are the same as the putative lymphocyte 
receptor for synovial HEV, or whether they represent unique recep-
tors mediatin g selective migration to the skin only. Although the 
mechanism of adherence was investi gated using rat lymphocytes 
beca use of the avai lability of the monoclona l reagents, preliminary 
experi ments with human peripheral blood lymphocytes and their 
subsets have supported our present finding. Moreover, it has been 
reported that anti-LFA-l monoclonal ant ibody blocks T-lympho-
cyte ad herence to cultured dermal microvascular endothelial cells 
[20] and keratinocytes [21 ]. and current studies in our laboratory are 
directed at defining the role ofLFA-1 and other cell adhesion mole-
Table IV. Differential Effect of Mannose-6-Phosphate on 
Lymphocyte Binding to Psoriatic and Lymph Node Endothelium 
Treatment of Cell ' LNb Skin SectionsC 
Mannose- I-PO. (10 mM) 36 ± 5 55 ± 5 
Control 42 ± 3 48 ± 3 
Mannose· I-PO. (0.1 111M) 52 ± 4 40± 6 
ontrol 59 ± 5 44 ± 4 
Mannose-6-PO. (10 mM) 6 ± 2" 57 ± 11 
Control 62 ± 4 41 ± 6 
Mannosc-6·PO. (0. I mM) 48 ± 6 32± 6 
ontro l 65 ± 8 46 ± 5 
,. TDL arc incubated ill RPMI medium containin g mannosc-l-PO .. or l1lannosc- 6-
PO, at the indicated concentration. After 30 min, the cells (10 X 10"/ml) arc overlaid 
onto human LN sections in the prescnce of the carbohydratc. 
l> Valu es arc Ilumber of positive HEV /scction ± S.E. for 4 sections. 
C Values arc number of cells bound/ 111m2 of section ± S.E. for 4 sectio ns. 
" p < 0.0 I by Student's t-tcst. 
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cules in the bindin g of human lymphocytes to psoriatic dermal 
endoth elium. 
The novel and hi g hl y specific inte rac tion we have demonstrated 
between CD4+ cells and endothelium of involved psoriatic skin is 
further ev idence for a probable role o f lymphocytes in the patho-
genesis of psoriasis. Previous studies [2 - 5) , includin g the successful 
treatment of psorias is with cyclosporin A [6], have a lready suggested 
tha t the immune system may be inv olved either in the initiation or 
persistence o f the excessive keratinocyte proliferation . Actual physi-
cal interactio n of specific lymphocytes with keratinocytes o r eve n 
Langerhans ce lls cou ld lead to the release of cytokines that would 
alte r keratinocyte growth. For example, it h as bee n shown that the 
local cutaneous transfer of T-cell clones induces a lichenoid tissue 
reaction and pro minent epidermotropic ce llular infiltrates [22J. Al-
ternatively, soluble m ediators released from lymphocytes recruited 
in psoriatic d ermis may affect keratinocyte growth and antigen ex-
press ion; supernatants of phytohemm agglutinin-stimulated T cel ls, 
but not interleukin-2, induce the expression of HLA-DR by kera-
tinocytes in culture [23]. These interactions between lymphocytes 
and keratinocytes m ost likely result in a dynamic set of ev ents th at 
might h ave both positive and negative effects on keratinocyte pro-
liferation in psoriasis . Thus, keratinocytes secrete a substance struc-
turally similar to inte rleukin-2 (24) , which is a trophic factor for T 
lymp hocytes and mi g ht help explain the preferentia l prolife ra tion 
of T ce lls in certain dermatologic disorders. H owever, T lympho-
cytes, when stimul ated, secrete up to 46 times more transforming 
growth factor-beta [25 ], w hich decreases th e proliferation of a vari-
e ty of cells, including keratinocytes [26] . 
W e studied establ ished psoriatic les ions showing continued clini-
cal progression. In light of the recent observations by Griffin e t a l 
[27J, it would be important in future studies to characterize further 
the "type" of psoriatic les ion inves ti gated in our lymphocyte-adhe-
sion assay. These authors have demonstrated the existence of 
"acute" and "chronic" areas in psoriatic plaques, which are distin-
guishabl e both clinically and histolog ically . The acute areas, unlike 
the chro nic ones, are resistant to topically administe red ste roids and 
show a persistence of vascular abnormalities. It is possible th at an 
unaba ted dermal influx of lymphocytes mediated by the altered 
psoriatic e ndoth elium is the reason why these acute areas do no t 
improve. 
O ur study does no t answer the fundam ental ques tion as to 
w heth er the primary defect in psorias is is in th e keratinocyte or the 
dermis, but does su ggest a mechanism by which the inflammatory 
infiltrate in psoriasis may be selectively recruited. A number of 
studies h ave shown that the endo thelial cell proliferation observed 
in the dermal papil lae of psoriatic skin persists after su ccessful heat-
ment [27,28]. T his o bservation is one of many su ggesting a ro le of 
dermal clements in the pathogenesis of psorias is, and future studies 
m ay estab lish whether this endothelial proliferation is mech anisti-
call y lin ked to th e expressio n by endothelial cells of surface li ga nds 
mediating lym phocyte adh erence. 
We thal1k Demitri A da rill es, R obill Va II II , alld Kevill J OIIIISO II Jar tec/Illical assisl-
alice alld M. Tia Maria for mOI/t/script preparatioll. 
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